Unknown NA INTERVENTIONAL 2-arm NCT04976413

Efficacy of EMDR in the Treatment of Depression and Comorbid Anxiety

Efficacy of Eye Movement Desensitization and Reprocessing (EMDR) Psychotherapy in the Treatment of Depression and Comorbid Anxiety: A Randomized Control Trial

Sponsor: Quaid-e-Azam University

Conditions Anxiety Depression

Interventions Counselling as usual Eye Movement Desensitization and Reprocessing (EMDR) psychotherapy

Updated 5 times since 2021 Last updated: May 18, 2022 Started: Feb 1, 2021 Primary completion: May 31, 2022 Completion: Aug 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Anxiety and Depression, this trial is ongoing. The trial is conducted by Quaid-e-Azam University and has accumulated 5 data snapshots since 2021. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Aug 2023 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jun 2022 — Aug 2023 [monthly]

Recruiting NA
Sep 2021 — Jun 2022 [monthly]

Recruiting NA

First recorded

Feb 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Quaid-e-Azam University

Data source: Quaid-e-Azam University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Islamabad, Pakistan